FDA Investigator Jennifer D Hollstrom
Jennifer D Hollstrom has conducted inspections on 16 sites in 5 countries as of 03 Mar 2008. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
03 Mar 2008
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Italy,
Ireland,
Canada,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Jennifer D Hollstrom:
Aaron P Wozniak,
Adalberto Cajigas,
Adam R Cooke,
Ademola O Daramola,
Amy H Ruble,
Ana Delp Cintron,
Ana P Barido,
Anthony Abel,
Ashar P Parikh,
Azza Talaat,
Barbara Jwilimczyk Macri,
Barbara M Frazier,
Billy M Battles,
Brittny C Cargo,
Carl A Anderson,
Carlos M Gonzalez,
CDR Ileana Barreto Pettit,
CDR Thomas R Berry, PPh,
Cherrie A Zachary,
Cheryl A Clausen,
Chiaochun J Wang,
Christian D Lynch (CDL),
Claire M Minden,
Craig A Garmendia,
Cynthia Jim, CSO,
Dandan Wang, PhD,
Daryl A Dewoskin,
Dawn M Mccabe,
Dennis Cantellops Paite,
Devaughn Edwards,
Deyaa Shaheen,
Dillard H Woody, Jr,
Donald C Obenhuber, PhD,
Donna Mwilliams Hill, PhD,
Douglas C Kovacs,
Dr. Carmelo Rosa,
Dyvette Arline,
Eileen J Bannerman,
Elizabeth Ll Edwards,
Erika V Butler,
Erin C Hill,
Erin D Mccaffery,
Erin Hill (EH),
Fabian Nchaparro Rodriguez,
Farhana Khan,
Gabriel R Mclemore,
George J Flynn,
Gerald B Seaborn, Jr,
Geraldine D Sanders,
Gideon N Esuzor,
Hai Lient Phung,
Hector A Carrero,
Ibad U Khan,
Jacqueline Mdiaz Albertini,
James A Lane,
James I Giefer,
Janet L Bowen,
Janis R Armedoriz,
Jared P Stevens,
Jason F Chancey,
Jawaid Hamid,
Jeffrey A Sommers,
Jennifer L Huntington,
Jennifer Lalama,
Jennifer M Menendez,
Jessica L Pressley,
Joanne E King,
Jocelyn E Massey,
Joey V Quitania,
Jogy George,
Jolanna A Norton,
Jose Acruz Gonzalez,
José E Meléndez,
Jose M Cayuela,
Joseph F Owens,
Karen G Hirshfield,
Kathleen D Culver,
Kelvin Cheung,
Kim Lthomas Cruse,
Larry K Hampton,
Laurel A Beer,
Lawrence Carter, III,
LCDR Debra Emerson,
LCDR Michael H Tollon,
Libia M Lugo,
LT Daveta L Bailey,
LT Tamara J Henderson,
Luis A Carrion,
Margaret L Bolte,
Maria V Price,
Marie F Morin,
Marvin D Jones,
Mary Jeanet Mcgarry,
Matthew B Casale,
Matthew R Dionne,
Melanie M Walker,
Michael L Casner,
Michael P Sheehan,
Michael R Goga,
Michael R Klapal,
Michele L Forster, PhD,
Michele L Obert,
Michelle Yclark Stuart,
Miguel A Martinez Perez,
Mihaly S Ligmond,
Mindy M Chou,
Monica Cburgos Garcia,
Mra Davism,
Mra Mcculloughj,
Nancy G Schmidt,
Niketa Patel,
Noreen Muñiz,
Omotunde O Osunsanmi,
Patricia H Dlugosz,
Paul L Figarole, Jr,
Penny H Mccarver,
Perry H Gambrell,
Prabhu P Raju,
Randy L Clarida,
Rebecca Rodriguez,
Renee S Blosser,
Rhonda Alexander,
Robert C Coleman,
Robert D Tollefsen,
Robert M Tillman,
Roger F Zabinski,
Rose Ashley,
Roy R Rinc,
Rozelle G Smith,
Russell J Glapion,
Salvatore N Randazzo,
Sandra A Hughes,
Sangeeta M Khurana, PhD,
Santos E Camara,
Sarah E Mcmullen,
Satheesh Thomas,
Saundrea A Munroe,
Seneca D Toms,
Shafiq S Ahadi,
Sharon K Thoma, PharmD,
Stephanie D Crockett,
Steve Y Rhieu, PhD,
Susan F Laska, MS,
Susan M Corrales,
Susan M Turcovski,
Susan P Bruederle,
Tamika D Cathey,
Tammara A Stephens,
Thomas E Friel,
Thomas J Arista,
Thomas R Withers,
Tonya R Johnson,
Torrance J Slayton,
Tracy R Ball,
Truong Xuan Nguyen (Andy),
Vicky C Stoakes,
Virginia L Meeks,
Viviana Matta,
Xiujing L Baggett,
Yong Hu,
Yuesheng Ye,
Yun Wu, PhD,
Zhong Li, PhD
Jennifer D Hollstrom's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| April, 2006 | FDA 483 | Actavis Laboratories FL, Inc. - Form 483, 2006-04-18 |
| September, 2006 | EIR | Novo Nordisk Pharmaceutical Industries, LP - EIR, 2006-09-22 |
| April, 2008 | FDA 483 | Actavis Laboratories FL, Inc. - Form 483, 2008-04-10 |
| July, 2005 | EIR | Patheon Manufacturing Services LLC - EIR, 2005-07-29 |
| September, 2007 | FDA 483 | JMI Daniels Pharmaceuticals, Inc - Form 483, 2007-09-21 |
| September, 2007 | EIR | JMI Daniels Pharmaceuticals, Inc - EIR, 2007-09-21 |
| March, 2007 | FDA 483 Response | Leiner Health Product, Llc - Form 483R, 2007-04-09 |
| September, 2006 | FDA 483 Response | Novo Nordisk Pharmaceutical Industries, LP - Form 483R, 2006-10-09 |
| March, 2007 | FDA 483 | Leiner Health Product, Llc - Form 483, 2007-03-16 |
| October, 2005 | FDA 483 | Newco Pharm LLC - Form 483, 2005-10-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more